BMRA
Biomerica IncNASDAQ
Healthcare • Medical Devices
$1.610.00%
Close Nov 6, 2026
- Market cap
- $5.31M
- 1 month
- -14.8%
- 3 months
- -1.2%
- 1 year
- -37.6%
- 52-week range
- $1.49$2.88
- Dividend
- No dividends on record
- Short interest
- 0.3% of float10.5K shares · settled Oct 15, 2026 · -62.1% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Aug 31, 2026
- Revenue
- $4.34M
- Net income
- -$5.01M
- Free cash flow
- -$3.99M
- Book value
- $3.65M
- Total debt
- $2.33M
- P/E
- —
- Price / sales
- 1.2×
- Price / book
- 1.5×
- FCF yield
- -75.2%
- Net margin
- -115.5%
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America.
Read more
The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients to aid in the diagnosis of diseases, food intolerances, and other medical conditions, as well as detect and measure the presence and levels of specific bacteria, hormones, antibodies, antigens, and other substances that may exist in the human body at extremely low concentrations through clinical laboratories and in point-of-care settings, including physicians' offices and over-the-counter channels. It also provides contract development and manufacturing services to third parties. In addition, the company commercializes inFoods IBS product through physician-directed and laboratory-based channels, such as third-party reimbursement pathways. Further, it is involved in the development and optimization of immunoassays, enzyme-linked immunosorbent assays, rapid diagnostic tests, and related diagnostic technologies; and research, development, commercialization of diagnostic-guided therapy (DGT) products to treat gastrointestinal diseases, such as irritable bowel syndrome (IBS), and other inflammatory diseases. Additionally, the company offers EZ detect colon disease home test; Aware Breast Self-Exam product; and hp+detect, a diagnostic test designed to detect Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
- Website
- biomerica.com
- Headquarters
- Irvine, CA, United States
- Employees
- 50
- Listed
- Jan 3, 2005
- Fiscal year ends
- May
Company profile from EODHD, stored Oct 25, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Aug 2026filed Oct 15, 2026 | $1.3M | -8.3% | 8.1% | -$1.2M | -$1.2M |
| May 2026filed Aug 31, 2026 | $875.0K | +16.8% | -8.1% | -$1.5M | -$1.1M |
| Feb 2026filed Apr 13, 2026 | $987.0K | -11.8% | -4.5% | -$1.3M | -$1.3M |
| Nov 2025filed Jan 14, 2026 | $1.2M | -26.0% | 4.2% | -$1.4M | -$1.3M |
| Aug 2025filed Oct 14, 2025 | $1.4M | -23.6% | 30.7% | -$1.1M | $2.0K |
| May 2025filed Aug 29, 2025 | $749.0K | -32.9% | -32.6% | -$1.6M | -$1.5M |
| Feb 2025filed Apr 14, 2025 | $1.1M | +10.0% | 1.7% | -$1.2M | -$1.2M |
| Nov 2024filed Jan 14, 2025 | $1.6M | +4.4% | 26.7% | -$993.0K | -$950.0K |
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| May 2026filed Aug 31, 2026 | $4.5M | -16.2% | 8.1% | -$5.3M | -$3.8M |
| May 2025filed Aug 29, 2025 | $5.3M | -1.9% | 9.4% | -$5.1M | -$5.0M |
| May 2024filed Aug 28, 2024 | $5.4M | +1.4% | 11.3% | -$6.4M | -$6.0M |
| May 2023filed Aug 25, 2023 | $5.3M | -71.7% | 8.4% | -$7.2M | -$7.1M |
| May 2022filed Aug 29, 2022 | $18.9M | +162.1% | 15.8% | -$4.5M | -$4.5M |
| May 2021filed Oct 14, 2021 | $7.2M | +7.6% | 5.1% | -$7.5M | -$7.4M |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched BMRA. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
10,485 shares short
-17,174 shares (-62.1%) vs Sep 30, 2026
0.3% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
27,659 shares short
-9,499 shares (-25.6%) vs Sep 15, 2026
0.7% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
37,158 shares short
-20,696 shares (-35.8%) vs Aug 31, 2026
1.3% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
57,854 shares short
+39,521 shares (+215.6%) vs Aug 14, 2026
Share of float unavailable. Published Sep 10, 2026.
Settlement Aug 14, 2026
18,333 shares short
-4,721 shares (-20.5%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
23,054 shares short
+996 shares (+4.5%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind BMRA’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
1 for 8 · reverse split
Effective Apr 21, 2025
Each 8 pre-split shares become 1 post-split share.
Source: EODHD
1 for 2 · reverse split
Effective Nov 14, 1994
Each 2 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if BMRA is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
3 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Oct 30, 2026
Insider context
Sentiment: bullish
Last trade: buy 72 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bullish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 7
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: bullish. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
21 filers reported a long position in BMRA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
99.5%
of the 129.6K shares 13-F filers reported
Moves vs Q1 2026
1 added1 trimmed
2 new · 6 unchanged
Net shares held
-21.9%
across the 8 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | HRT FINANCIAL LP | $46K · 26.4K shares | 26.4K | New |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | $42.9K · 24.3K shares | 24.3K | -56.6% |
| 3 | BlackRock, Inc. | $32.8K · 18.6K shares | 18.6K | Unchanged |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | $25.5K · 14.5K shares | 14.5K | Unchanged |
| 5 | JANE STREET GROUP, LLC | $22.2K · 12.6K shares | 12.6K | New |
| 6 | LPL Financial LLC | $19.1K · 10.8K shares | 10.8K | Unchanged |
| 7 | UBS Group AG | $12.2K · 7K shares | 7K | +1,239.3% |
| 8 | VANGUARD FIDUCIARY TRUST CO | $11.6K · 6.6K shares | 6.6K | Unchanged |
| 9 | BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. | $7.7K · 4.3K shares | 4.3K | Unchanged |
| 10 | NewEdge Advisors, LLC | $6.3K · 3.6K shares | 3.6K | Unchanged |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inGet the Full Analysis for BMRA
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.